Sunday , April 11 2021

Oncology Pharma Signs License Agreement for mRNA Intellectual Property As It Reveals Strategic Plans for Treating Pancreatic Cancer – BioSpace

SAN FRANCISCO, CA / ACCESSWIRE / April 7, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) signed a license agreement with Regen BioPharma Inc. for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. This license agreement expands the Company's portfolio of intellectual property that It plans to develop for niche biotechnology markets. Oncology Pharma issued a statement "We are looking to expand our presence in the cancer therapy market. This ...

 

Read the full article here


CHASE SAPPHIRE PREFERRED® 60,000 BONUS POINTS After you spend $4,000 on purchases in the first 3 months from account opening*Same page link to Offer Details — that's $750 toward travel when you redeem through Chase Ultimate Rewards®

  Of Interest

-- END RSP MOD -->